ApoAI ELISA Kit

Human ApoAI ELISA Kit

Cat. Num. AAA168533

• Synonyms: ApoAI; Human ApoAI ELISA Kit; ApoAI elisa kit

• Samples: Plasma, serum or other biological fluid samples
• Preparation and Storage: Upon receipt, aliquot and store the Human ApoAI Standard at -20 degree C to avoid multiple freeze/thaw cycles. Store all other components at 4 degree C.

Typical Testing Data/Standard Curve (for reference only)

Related Product Information for ApoAI elisa kit

Background: Lipoproteins are submicroscopic particles composed of lipid and protein held together by noncovalent forces. Their general structure is that of a putative spheroidal microemulsion formed from an outer layer of phospholipids, unesterified cholesterol, and proteins, with a core of neutral lipids, predominately cholesteryl esters and triacylglycerols (TAG). Plasma apolipoproteins can be grouped into two classes: the nonexchangeable apolipoproteins (ApoB-100 and ApoB-48), and the exchangeable apolipoproteins (ApoAI, ApoAII, ApoAIV, ApoCI, ApoCII, ApoCIII, and ApoE). ApoAI comprises approximately 70% of the protein moiety in HDL (Figure 1). It is a single polypeptide chain consisting of 223 amino acid residues without disulfide bond and with aspartic acid as the the N-terminal residue and glutamic acid as the C-terminal residue. It has an approximate molecular weight 28 kDa. ApoAI activates lecithin-chlesterol (LCAT) acyltransferase, which is responsible for cholesterol esterification in plasma. Human ApoAI ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of human ApoAI in plasma, serum or other biological fluid samples. The kit has detection sensitivity limit of 50 pg/mL human ApoAI. Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples.

Product Categories/Family for ApoAI elisa kit

Metabolism Research; Lipoprotein Metabolism; Apolipoprotein ELISA Kits; Human Apo AI ELISA Kit

References

1. Segrest J. P., Garber D. W., Brouillette C. G., Harvey S. C., and Anantharamaiah G. M. Adv. Protein Chem. 45: 303-369, 1994.
2. Segrest J. P., Jones M. K., De Loof H., Brouillette C. G., Venkatachalapathi Y. V., and Anantharamaiah G. M. J. Lipid Res. 33: 141-166, 1992.
3. Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., Chea, H., Knopp, R. H., Brunzell, J., Geary, R., Chait, A., Zhao, X. Q., Elkon, K., Marcovina, S., Ridker, P., Oram, J. F., and Heinecke, J. W. J. Clin. Investig. 117, 746-756, 2007.
4. Tailleux, A., Duriez, P., Fruchart, J. C., and Clavey, V. Atherosclerosis 164, 1-13, 2003.